Header Logo

Connection

Susanna Ulahannan to RNA, Messenger

Back to Details
This is a "connection" page, showing publications Susanna Ulahannan has written about RNA, Messenger.
Susanna Ulahannan
Connection Strength
0.028
RNA, Messenger
  1. Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer. Int J Cancer. 2016 10 01; 139(7):1648-57.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.